Sculptor Capital’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Sculptor Capital’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,019,653	Closed	-$20.2M	–	1213
2022 Q3	$20.2M	Buy	2,019,653 +19,428	+1%	+$193K	0.25%	64
2022 Q2	$19.8M	Buy	2,000,225 +1,019,730	+104%	+$10.1M	0.21%	78
2022 Q1	$9.67M	Buy	980,495 +505,499	+106%	+$4.96M	0.07%	264
2021 Q4	$4.66M	Buy	474,996 +274,996	+137%	+$2.71M	0.04%	400
2021 Q3	$1.96M	Hold	200,000	–	–	0.02%	481
2021 Q2	$1.98M	Buy	200,000 +100,000	+100%	+$1.01M	0.01%	513
2021 Q1	$1.03M	Sell	100,000 -200,000	-67%	-$2.22M	0.01%	490
2020 Q4	$3.23M	Buy	+300,000	New	+$3.21M	0.01%	250

Sculptor Capital's LUXA Position: Q4 2022 in Review

Sculptor Capital sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 2,019,653 shares — an estimated $20.2M sold.

Sculptor Capital first reported a position in LUXA in Q4 2020 and held it in 8 quarters. The position peaked at $20.2M in Q3 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

Sculptor Capital reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Sculptor Capital sold 2,019,653 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $20.2M.
Sculptor Capital first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q4 2020 and held it in 8 quarters.
Sculptor Capital's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $20.2M in Q3 2022.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Sculptor Capital's 13F filing for Q4 2022, filed 14 Feb 2023.